This NIH grant enhances the rigor and reproducibility of dietary supplement research by supporting formal single-laboratory validation studies of analytical methods. These methods are vital for accurately identifying and quantifying dietary supplement-relevant ingredients, constituents (like active compounds, adulterants, or contaminants), or their metabolites in experimental reagents, raw materials, or clinical specimens (e.g., urine, plasma). Proposed methods must already be developed or utilized within an active parent grant. Candidate constituents include phytochemicals, nutrients, and potentially deleterious substances such as pesticides or mycotoxins. This grant specifically supports single-laboratory validations, excluding multi-laboratory studies. The aim is to disseminate reliable analytical tools crucial for both basic and clinical research on natural products.
Opportunity ID: 328410
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-20-252 |
| Funding Opportunity Title: | Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 30, 2020 |
| Last Updated Date: | Jul 30, 2020 |
| Original Closing Date for Applications: | Apr 15, 2022 |
| Current Closing Date for Applications: | Apr 15, 2022 |
| Archive Date: | May 21, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Small businesses Native American tribal governments (Federally recognized) County governments City or township governments Special district governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The rigor and reproducibility of research on dietary supplements is enhanced by rigorous characterization of key experimental resources and biological samples. The dissemination of analytical methods that are validated to accurately and reliably characterize dietary supplements and quantify their constituents and/or metabolites is vital for both basic and clinical research. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of analytical methods for dietary supplements and other natural products. The method(s) proposed for validation must be used to identify and/or quantify dietary supplement-relevant ingredients or constituents (i.e., active or marker chemical compounds, adulterants, contaminants) or their metabolites in experimental reagents, raw materials, and/or clinical specimens (e.g., urine or plasma samples). The method(s) must already be developed or utilized in fulfillment of the active parent grant’s specific aims. Candidate constituents for method validation studies include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-20-252.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 328410 Full Announcement-PA-20-252 -> PA-20-252-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F-ADMINSUPP-CAREERDEV | Use for due dates on or before January 24, 2022 | PKG00262827 | Sep 15, 2020 | Jan 24, 2022 | View | |
| FORMS-F-ADMINSUPP-TRAINING | Use for due dates on or before January 24, 2022 | PKG00262828 | Sep 15, 2020 | Jan 24, 2022 | View | |
| FORMS-F-ADMINSUPP-FELLOWSHIP | Use for due dates on or before January 24, 2022 | PKG00262829 | Sep 15, 2020 | Jan 24, 2022 | View | |
| FORMS-F-ADMINSUPP-RESEARCH | Use for due dates on or before January 24, 2022 | PKG00262844 | Sep 14, 2020 | Jan 24, 2022 | View | |
| FORMS-G-ADMINSUPP-CAREERDEV | Use for due dates on or after January 25, 2022 | PKG00270981 | Sep 15, 2020 | Apr 15, 2022 | View | |
| FORMS-G-ADMINSUPP-TRAINING | Use for due dates on or after January 25, 2022 | PKG00270996 | Sep 15, 2020 | Apr 15, 2022 | View | |
| FORMS-G-ADMINSUPP-RESEARCH | Use for due dates on or after January 25, 2022 | PKG00270997 | Sep 14, 2020 | Apr 15, 2022 | View | |
| FORMS-G-ADMINSUPP-FELLOWSHIP | Use for due dates on or after January 25, 2022 | PKG00270998 | Sep 15, 2020 | Apr 15, 2022 | View |
Package 1
Mandatory forms
328410 RR_SF424_2_0-2.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_2_0-2.0.pdf
328410 RR_KeyPersonExpanded_2_0-2.0.pdf
328410 RR_Budget10_1_4-1.4.pdf
328410 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf
Optional forms
328410 RR_SubawardBudget10_30_1_4-1.4.pdf
328410 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Package 2
Mandatory forms
328410 RR_SF424_2_0-2.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_2_0-2.0.pdf
328410 RR_KeyPersonExpanded_2_0-2.0.pdf
328410 PHS398_ResearchTrainingProgramPlan_4_0-4.0.pdf
Optional forms
328410 RR_Budget10_1_4-1.4.pdf
328410 RR_SubawardBudget10_30_1_4-1.4.pdf
328410 PHS398_TrainingBudget-1.0.pdf
328410 PHS398_TrainingSubawardBudget_2_0-2.0.pdf
Package 3
Mandatory forms
328410 RR_SF424_2_0-2.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_2_0-2.0.pdf
328410 RR_KeyPersonExpanded_2_0-2.0.pdf
328410 PHS_Fellowship_Supplemental_5_0-5.0.pdf
Optional forms
328410 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Package 4
Mandatory forms
328410 RR_SF424_2_0-2.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_2_0-2.0.pdf
328410 RR_KeyPersonExpanded_2_0-2.0.pdf
328410 PHS398_ResearchPlan_4_0-4.0.pdf
328410 RR_Budget10_1_4-1.4.pdf
Optional forms
328410 RR_SubawardBudget10_30_1_4-1.4.pdf
328410 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Package 5
Mandatory forms
328410 RR_SF424_5_0-5.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_4_0-4.0.pdf
328410 RR_KeyPersonExpanded_4_0-4.0.pdf
328410 RR_Budget10_3_0-3.0.pdf
328410 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf
Optional forms
328410 RR_SubawardBudget10_30_3_0-3.0.pdf
328410 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Package 6
Mandatory forms
328410 RR_SF424_5_0-5.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_4_0-4.0.pdf
328410 RR_KeyPersonExpanded_4_0-4.0.pdf
328410 PHS398_ResearchTrainingProgramPlan_4_0-4.0.pdf
Optional forms
328410 RR_Budget10_3_0-3.0.pdf
328410 RR_SubawardBudget10_30_3_0-3.0.pdf
328410 PHS398_TrainingBudget_2_0-2.0.pdf
328410 PHS398_TrainingSubawardBudget_3_0-3.0.pdf
Package 7
Mandatory forms
328410 RR_SF424_5_0-5.0.pdf
328410 PHS398_CoverPageSupplement_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_4_0-4.0.pdf
328410 RR_KeyPersonExpanded_4_0-4.0.pdf
328410 PHS398_ResearchPlan_4_0-4.0.pdf
328410 RR_Budget10_3_0-3.0.pdf
Optional forms
328410 RR_SubawardBudget10_30_3_0-3.0.pdf
328410 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Package 8
Mandatory forms
328410 RR_SF424_5_0-5.0.pdf
328410 RR_OtherProjectInfo_1_4-1.4.pdf
328410 PerformanceSite_4_0-4.0.pdf
328410 RR_KeyPersonExpanded_4_0-4.0.pdf
328410 PHS_Fellowship_Supplemental_6_0-6.0.pdf
Optional forms
328410 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
